Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

FORGOTTEN HISTORY: 12 | History Defined

Amid the Fed’s monetary policy tightening and the recent financial sector turmoil, fears of an economic slowdown have soared, which in turn induced market volatility. Given this backdrop, quality stocks Comcast Corp. (CMCSA), Medtronic (MDT), and GSK plc (GSK) might be solid buys today. Read on….

StockNews.com

New study recommends better vaccine deal for adults

Older Australians are being left behind by Australia's national immunisation program, with health advocates calling on the government to reform the system.

AAP

Burberry Appoints McLaren's Kate Ferry as CFO

British luxury brand Burberry said on Wednesday it had appointed Kate Ferry as its next chief financial officer, succeeding Julie Brown, who is joining GSK. Ferry, who is currently chief financial officer at Formula One and luxury car firm McLaren Group, will join Burberry by early September at the latest,…

Asharq Al-Awsat

From analysis to the latest developments in health,
read the most diverse news in one place.

Joe Lycett and Sam Smith lead Rainbow Honours nominees as iconic venue for awards revealed

Joe Lycett's protest against David Beckham's controversial deal with Qatar has been nominated for yet another prestigious award, with Sam Smith, Graham Norton, Andrew Garfield, Dame Kelly Holmes and more also recognised in the Rainbow Honours shortlist

Daily Mirror

Pfizer’s RSV vaccine just won an FDA panel’s backing for safety in older people. It's a market that will be worth up to $10 billion in a decade

Pfizer is also facing off with collaborators Sanofi and AstraZeneca Plc to develop prevention for dangerous RSV infections in newborns, a market that could reach $1.5 billion.

Fortune

Pfizer’s RSV vaccine wins US panel’s backing for safety in older people

WASHINGTON — Pfizer Inc.’s vaccine for respiratory syncytial virus received endorsement from a key panel of U.S. advisers for its safety in people 60 and older, a key endorsement for the drugmaker’s potential product.

Tribune News Service

Eamonn Holmes talks putting personal and work life on hold as thanks to shingles

"I wasn’t aware of what I had; I looked in the mirror, I had no idea what I was looking at except this hideously blistered face"

Wales Online

Read news from The Economist, FT, and more,
with one subscription

Eamonn Holmes on his experience with shingles saying 'It scared the life out of me'

"When you look at the factors for both of us, we had both gone through stressful experiences, your bereavement, me a court case..."

Belfast Live

Is there a vaccine for RSV or respiratory syncytial virus? After almost 60 years, several come at once

You might not have heard of respiratory syncytial virus, or RSV. But it caused more than 100,000 global deaths in 2019, making it a leading cause of death in children under one year old.

The Conversation

Revealed: how many days FTSE 100 companies have staff in the office

Hybrid and flexible working is offered at most FTSE 100 companies, survey results suggest

Evening Standard

Office days: The full list of average weekly working patterns at FTSE 100 companies

Here is the full list of respondents and their feedback to a Evening Standard survey looking at weekly working patterns, writes Joanna Hodgson

Evening Standard

A technicality could withhold RSV shots

A glitch in a law may make it difficult for children from low-income families to get the new RSV vaccine

Salon

Workers resume strike action as union admit dispute could drag on

Unite chiefs say their members are determined to get 'what they are owed' in bonus payments row.

Daily Record

3 Pharma Stocks to Buy in 2023 and Hold for Decades

The pharmaceutical industry is well-positioned for significant growth in the near future, given the growing demand for medicines and increasing R&D activities. Given the industry's inelastic demand, fundamentally strong pharma stocks AstraZeneca (AZN), Bristol-Myers Squibb (BMY), and GSK plc (GSK) might be solid long-term investments. Continue reading….

StockNews.com

Get all your
news in one place.

100's of premium titles.
One news app.

The Guardian - UK

GSK boss warns UK life sciences at ‘tipping point’ despite Sunak’s R&D pledge

Emma Walmsley says ambition to be pharma superpower at risk unless improvements made in key areas

Evening Standard

FTSE 100 Live: Vodafone revenues fall in Europe, GSK profits rise

Interest rates are today expected to rise another 0.5% to 4% as the Bank of England continues the fight against inflation with its 10th increase in a row.

The Independent UK

Relief for millions of UTI sufferers with new medicine breakthrough

Experts are calling gepotidacin a massive step forwards in the fight against resistance to antibiotics

Daily Record

Kilwinning roadworks alert as 'frustrating' disruption set to last for one month

Roads to be dug up as a result of cabling work.

Get all your
news in one place.

100's of premium titles.
One news app.

StockNews.com

3 Must Have Pharma Stocks in January 2023

Rising rates of chronic diseases, an aging population, and increasing healthcare spending should drive the pharma industry’s growth in the upcoming years. Moreover, pharma companies perform steadily regardless of economic conditions due to the inelastic demand for their products. Therefore, it could be wise to invest in fundamentally strong pharma…

Daily Record

GSK facing months of industrial action as workers go on strike at pharma giant

Electricians, scaffolders, cable pullers and labourers have downed tools in a dispute over bonus payments.

Evening Standard

GSK to move back to central London with new HQ

Six floor office building on New Oxford Street will be workplace for 3,000 staff including CEO

The Guardian - UK

Moonpig flotation price, like so many, was always pie-in-the-sky thinking

You’d think fund mangers would have deployed degree of scepticism after years of overvalued businesses

The Guardian - UK

GSK shares surge as US judge dismisses Zantac cancer claims

About 50,000 federal lawsuits claimed that the best-selling heartburn drug had led to cancer

The Guardian - UK

AstraZeneca looks fighting fit despite the ills of the UK science sector

Brexit fallout plus funding fears mean an uncertain prognosis, but the firm will report good news this week

The Guardian - UK

Mark Zuckerberg’s metaverse is a joke not shared by investors

Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations